Ultrafreezer loan program for receiving and storing messenger RNA vaccines
In yet another action by the Unicamp Task Force to combat Covid-19, with the aim of analyzing the ultrafreezer park in the Campinas region and considering the possibility of purchasing messenger RNA vaccines in Brazil, which require storage in low temperatures in ultrafreezers (-70°C), we are carrying out a survey to verify the capacity of Unicamp and research institutes and companies in the Campinas region to make ultrafreezers available for a specific period (February 2021 to February 2022) for storing vaccines, if they are acquired and incorporated into the PNI/SUS for distribution.
In this first moment, the idea is to find out the availability of these ultrafreezers, communicate it to the Health Department of Campinas City Hall and neighboring cities, which can use the infrastructure as a strategic support point for the distribution of vaccines in the region.
The requirements for the availability of ultrafreezers are:
- FREEZER TYPE ULTRA LOW TEMPERATURE -80°C/CO2 BACKUP
- Be connected to a generator
- Have a backup system with CO2 cylinder (injection to maintain temperature)
- Have a temperature monitoring system that sends messages to your cell phone
- Have undergone maintenance/revision in the last 5 years
- Be dedicated exclusively to storing vaccines
Even a freezer that does not meet all of these criteria may be considered. For ultrafreezers that do not meet all of the above requirements, there is the possibility of hiring a specialized technical service for a simplified review of operation and installation of the backup and temperature monitoring system. In this sense, we hope to count on support from companies and entrepreneurs in the region.
To evaluate the characteristics of your ultrafreezer and its availability to meet future demands, please fill out the form here.
If you have any questions or clarifications, please contact:
Prof. Luiz Carlos Dias (ldias@unicamp.br)
Chemistry Institute
Member of the Unicamp Task Force to combat Covid-19
